GOVX: GeoVax Labs, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
GURU.Markets platformasidagi o'sishga yo'naltirilgan P/E grafigi GeoVax Labs, Inc. (GOVX) kompaniyasining salohiyatini namoyish etadi, uning kelgusi daromadlari MVA tizimi orqali Marburg va Zika isitmasi vaksinalarining sotuviga asoslangan. 0.00 ko'rsatkichi kompaniya saraton bilan kurashish uchun genetik platformalarni monetizatsiya qilayotgan vaqtda parametrning joriy holatini aks ettiradi. Shu bilan birga, AQSh hukumati grantlari geosiyosiy xatarlarni minimallashtirib, ishlanmalar barqarorligini ta'minlaydi.
GeoVax Labs, Inc. (GOVX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati GeoVax Labs, Inc.|GOVX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi geovax.com|GOVX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar GeoVax Labs Inc|GOVX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarzdorlik GeoVax|Shoshilinch likvidlik geovax.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
GOVX - Kompaniyaning sof foydasi|Kutilayotgan sof foyda GeoVax Labs, Inc.|GOVX - Narx-foyda koeffitsiyenti|Kelajakdagi narxning foydaga nisbati GeoVax Corp|GOVX - PEG multiplikatori|EV/EBITDA multiplikatori GeoVax Labs Inc|GOVX - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi 12 oy davomida bir aksiya uchun foyda GeoVax|GOVX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi geovax.com|GOVX - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi GeoVax Labs, Inc.
Kompaniyaning umumiy tahlili:GOVX - GeoVax Labs
GeoVax Labs, Inc. (GOVX) MVA platformasiga asoslangan noyob vaksinalarni ishlab chiqadi, bunda muvaffaqiyat eksklyuziv ravishda FDA tasdig'iga bog'liq. peg_co koeffitsiyenti bozor narxining adolatli ekanligini aniqlash uchun joriy P/E koeffitsiyentini foyda o'sish sur'atlari bilan solishtiradi. Bir birlikdan past qiymat aktivning kengayishiga nisbatan qadrsizlanganligini anglatadi. Investorlar yuqori potensialga ega qadrsizlangan "raketalar"ni aniqlash uchun ushbu filtrdan foydalanadilar. peg_co koeffitsiyenti dinamikasi xavf va daromad muvozanatini saqlashga yordam beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Pharvaris Pharma (PHVS)|ABCL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda tourmalinebio.com (TRML)|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|O‘sish sur’atiga tuzatilgan narx-foyda Pharming Group NV PHAR|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|Narxning foydaga va o‘sish sur’atiga nisbati UPB (Upstream Pharma)|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|PEG multiplikatori immunome.com IMNM|GOSS: Narx-foyda va o‘sish multiplikatori|KALV (KalVista Pharma) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|Pieris Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Savara Inc.|Narxning foydaga va o‘sish sur’atiga nisbati RIGL|PEG multiplikatori ANAB|PEG multiplikatori Astria Therapeutics Inc (ATXS)|PEG multiplikatori ENGN (enGene Bio)|rapt.com - Narxning foydaga va o‘sish sur’atiga nisbati|JBIO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aclaristx.com ACRS|KYTX (Kyverna Therapeutics, Inc.) - Narx-foyda va o‘sish multiplikatori|Tiziana Life Sciences Ltd. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|Ventyx Biosciences, Inc (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Theratechnologies Inc. (THTX)|avalotx.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ELDN (Eledon Pharmaceuticals, Inc.)|AGEN - Narx-foyda va o‘sish multiplikatori|CLYM: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati zurabio.com ZURA|ATYR: PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Adagene Inc. ADAG|Narxning foydaga va o‘sish sur’atiga nisbati ImageneBio|O‘sish sur’atiga tuzatilgan narx-foyda Shattuck Therapeutics STTK|Narx-foyda va o‘sish multiplikatori EQ (Equillium, Inc.)|Narxning foydaga va o‘sish sur’atiga nisbati CNTB (connectbiopharm.com)|Immunic - Narx-foyda va o‘sish multiplikatori|ATRA: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati XFOR|ACET: PEG multiplikatori|Celularity - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|INMB (INmune Bio, Inc.) - PEG multiplikatori|PEG multiplikatori barinthusbio.com|Narxning foydaga va o‘sish sur’atiga nisbati Kezar Life Sciences, Inc. (KZR)|SABS (SAB Biotherapeutics Inc.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Akari Therapeutics plc AKTX|ENLV - Narx-foyda va o‘sish multiplikatori|Q32 Bio Corp - PEG multiplikatori|EDSA - PEG multiplikatori|IBIO (iBio) - Narx-foyda va o‘sish multiplikatori|Carisma Therapeutics Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|Bolt Bio (BOLT) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|Narx-foyda va o‘sish multiplikatori aptevotherapeutics.com APVO|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|ADTX - Narx-foyda va o‘sish multiplikatori|GRI: Narx-foyda va o‘sish multiplikatori|XRTX - PEG multiplikatori|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti REVB|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Scinai Immunotherapeutics Ltd SCNI|PEG multiplikatori CALI|affimed.com (AFMD) - Narxning sof foyda o‘sishiga nisbati|PEG multiplikatori ALLK (Allakos)|HOOKIPA Pharma, Inc. (HOOK) - O‘sish sur’atiga tuzatilgan narx-foyda|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda iTeos Therapeutics Inc|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TCBP (TC BioPharm Ltd) - Narxning foydaga va o‘sish sur’atiga nisbati|THRD (Third Harmonic Bio) - PEG multiplikatori
